New GBIP in Singapore - Health & Medical Technologies

Innovate UK is inviting ambitious innovative companies to participate in its Global Business Innovation Programme (GBIP).

Applications will be considered from a wide range of innovative Medical & Health Technologies companies that focus on, but not limited to:

• Medical devices such as diagnostic equipment, surgical instruments, orthopaedic devices, dental devices, ophthalmic devices, wound care products.
• In-vitro diagnostics such as blood testing kits, point-of-care testing, molecular diagnostics.
• Therapeutic devices such as infusion pumps, dialysis machines, respiratory devices, insulin pumps, cardiovascular devices.
• Implants and biocompatible devices such as cardiac implants, neurostimulation devices, cochlear implants, orthopaedic implants, dental implants.
• Health monitoring and wearable devices such as wearable health trackers, remote patient monitoring, telemedicine devices, software solutions for clinical decision support and health information exchange.
• Robotic and AI-assisted devices such as robotic surgery systems, AI diagnostic tools.

Areas of focus that are not being considered for this GBIP are:

• Therapeutics and medicines such as cell and gene therapies, antibiotics, vaccines, biologics and tissue engineering.
• Sterilisation and infection control products such as but not limited to autoclaves, disinfectants and sanitizers and personal protective equipment.

Why Singapore?

Singapore’s Research, Innovation and Enterprise 2025 Plan aims to better transform and protect health, advance human potential & create economic value for Singapore. Priorities include transforming and protecting health through (i) shifting the focus towards both health promotion & disease prevention as the population ages (ii) supporting the health system to become more data-driven and patient-centric to deliver value-based care through the innovative use of both technology and digital solutions at scale (iii) using data analytics to support public health actions & telemedicine to deliver quality care to the wider population and (iv) expanding the national precision medicine research programme. A further priority is maximising economic value by growing a vibrant mix of start-ups and scale-ups with a strong translational ecosystem, with a particular focus on biotech companies.

Key dates

Applicant briefing – Wednesday 9th July, 10-11am
Application deadline – Sunday 24th August
Application outcome – Friday 5th September
Get ready workshop – Tuesday 16th & Wednesday 17th September
Market Visit – Saturday 15th to Friday 21st November
Exploit the opportunity workshop – Wednesday 11th February 2026

Find out more and apply